Original Research
Kelly F. Bell, PharmD, MSPhr, MS; Katherine Cappell, PhD; Michael Liang, MS; Amanda M. Kong, MPH
Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence
Brian Caveney, MD, JD, MPH
Todd Williamson, PhD, MSc, Rajesh Kamalakar, MS, Augustina Ogbonnaya, MPH, Erin A. Zagadailov, PharmD, MS, Michael Eaddy, PharmD, PhD, Charlie Kreilick, MBA
Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD,
MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA
The Challenge of Rosacea Treatment
Atheer A. Kaddis, PharmD
Tope Olufade, PhD, MPH, Amanda M. Kong, MPH, Nicole Princic, MS, Paul Juneau, MS, Rucha Kulkarni, MPH, Kui Zhang, MD, Catherine Datto, MD, MS
Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni,
MPH; Kui Zhang, MD; Catherine Datto, MD, MS
The Opioid Epidemic: Healthcare Utilization and Cost Considerations
Jack E. Fincham, PhD, RPh
Jill R. Davis, MS, Bingcao Wu, MS, David M. Kern, PhD, Ozgur Tunceli, PhD, Kathleen M. Fox, PhD, John Horton, MS, Randall F. Legg, PharmD, MBA, Frank Trudo, MD, MBA
Jill R. Davis, MS; Bingcao Wu, MS; David M. Kern, PhD; Ozgur Tunceli, PhD; Kathleen M. Fox, PhD;
John Horton, MS; Randall F. Legg, PharmD, MBA; Frank Trudo, MD, MBA
When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD
Michael F. Murphy, MD, PhD
Bettina M. Beech, DrPH, MPH, Tristan Cordier, MPH, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD
Bettina M. Beech, DrPH, MPH; Tristan Cordier, MPH; Laura E. Happe, PharmD, MPH; Laura Trunk, MD;
Gilbert S. Haugh, MS; Richard Kwong, MPH; Vipin Gopal, PhD; Roy A. Beveridge, MD
Patients’ Choice for Site of Care Motivated by More Than Cost Alone
James T. Kenney, Jr, RPh, MBA
An Ounce of Prevention Is Not a Choice a Patient Gets to Make for Late-Stage Cancer
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
Joseph Tkacz, MS, Michael P. Ingham, MSc, Brenna L. Brady, PhD, Roxanne Meyer, PharmD, Charles Ruetsch, PhD
Rashad Carlton, PharmD, MSPH, Rajiv Mallick, PhD, Chelsey Campbell, PharmD, MBA, Aditya Raju, MS, BPharm, Thomas O'Donnell, MD, Michael Eaddy, PharmD, PhD, Michael Eaddy, PharmD, PhD, Michael F. Murphy, MD, PhD
Counting on a Run of Value-Based Benefit Design